Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Bioxel researchers claim new taxane-carbohydrate conjugates

Sep. 8, 2004

Novel Bcr-Abl kinase inhibitors prepared and tested at Sloan-Kettering

Sep. 8, 2004

BMS patent covers new tyrosine kinase inhibitors for use in cancer therapy

Sep. 8, 2004

Antitumor effects of an oblimersen/docetaxel combination in hormone-refractory prostate cancer

Sep. 8, 2004

Fujisawa claims new HDAC inhibitors for immune disorders, cancer, etc.

Sep. 7, 2004

NV-1020 enters phase I/II study for liver metastases

Sep. 7, 2004

Suppression of testosterone by abiraterone acetate in prostate cancer patients

Sep. 7, 2004

Bolder Biotechnology receives SBIR grants for oncology efforts

Sep. 6, 2004

Celsion cleared to conduct phase I study of ThermoDox in liver cancer

Sep. 3, 2004

MGI Pharma and SuperGen sign license agreement for Dacogen

Sep. 3, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.